Table 4 Univariate and multivariate Cox survival analysis between two groups in FSGS patients.
From: A new index for the outcome of focal segmental glomerulosclerosis
Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|
HR (95% CI) | P-value | HR (95% CI) | P-value | ||
F2 | 2.78 (1.30–5.93) | 0.008 | 2.306 (1.022–5.207) | 0.044 | |
URBC (µ/µl) | |||||
26–50 | 0.25 (0.08–0.81) | 0.020 | |||
51–100 | 0.52 (0.21–1.26) | 0.149 | |||
> 100 | 0.30 (0.09–0.94) | 0.039 | |||
Creatinine (µmol/l) | |||||
121–200 | 3.023 (1.26–7.29) | 0.014 | 2.85 (1.01–3.55) | 0.045 | |
201–300 | 9.16 (2.54–32.99) | 0.001 | 15.85 (3.55–52.87) | 0.022 | |
> 300 | 2.76 (0.62–12.20) | 0.181 | 6.75 (2.10–35.12) | 0.035 | |
CKD stage | |||||
CKD2 | 3.04 (1.03–8.93) | 0.044 | |||
CKD3 | 3.65 (1.22–10.92) | 0.021 | |||
CKD4 | 3.84 (1.02–14.44) | 0.047 | |||
CKD5 | 7.96 (1.86–34.19) | 0.005 | |||
GSR | |||||
< 10% | 0.17 (0.02–1.39) | 0.098 | |||
19–20% | 1.22 (0.35–4.22) | 0.753 | |||
> 20% | 2.22 (0.93–5.29) | 0.072 | |||
T score | |||||
T1 | 1.99 (0.91–4.35) | 0.087 | |||
T2 | 4.91 (1.74–13.84) | 0.003 | |||
Treatment | |||||
Glucocorticoids | 0.477 (0.277–0.822) | 0.008 | |||
